← k3vl4r
Log inGet started →

LXEO (Lexeo Therapeutics Inc) Price Forecast

AI-generated price forecast for Lexeo Therapeutics Inc (LXEO) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's calibrated AI forecast currently reads LXEO as 1/1 bearish across its horizons (0 of 1 timeframes pointing up), with a last price of 3.04. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP🔬 Deep research

Last price

3.04

AI outlook

1/1 bearish

Timeframes up

0 / 1

Share𝕏PostTelegram

LXEO forecast by horizon

HorizonDirectionCalibrated move (end of horizon)
1-hour——
4-hour——
Daily~4 weeks out▼ Down-53.87%
WeeklyNot enough track record yet—

Calibrated: each horizon's forecast is weighted by how often the model has called LXEO's direction correctly over the last 30 days, and reversed where it has been wrong more often than right. A horizon votes only once it has enough resolved forecasts.

Latest LXEO news

From the market-news feed the forecasts are read against.

  • Lexeo Therapeutics Eyes NSVT Data as Key Test for LX2020 Gene Therapy · ldr:themarketsdaily.com · Oct 25
  • Lexeo Therapeutics Maps Gene Therapy Milestones, Eyes Key 2027 Readout · Yahoo · Oct 25
  • Lexeo Therapeutics, Inc. (LXEO) Discusses Clinical Assessment and Unmet Need in PKP2 Arrhythmogenic Cardiomyopathy - Slideshow · ldr:seekingalpha.com · Oct 24
  • Lexeo Therapeutics, Inc. (LXEO) Discusses Clinical Assessment and Unmet Need in PKP2 Arrhythmogenic Cardiomyopathy Transcript · SeekingAlpha · Oct 21
  • Lexeo Therapeutics to Host Educational Event Focused on Clinical Endpoints and Outcome Measures in PKP2-ACM · Yahoo · Oct 19

🔒

See the full LXEO forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

LXEO forecast — frequently asked

Will LXEO go up?

K3vl4r's calibrated AI forecast currently reads LXEO as 1/1 bearish — 0 of 1 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the LXEO price prediction for 2026?

K3vl4r's model projects LXEO toward $1.41 over the next ~4 weeks, a -53.9% move from $3.06. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Healthcare forecasts — browse the full sector.

More AI forecasts

ASTHQURECPHIACHAXSMWRBYWVECYTKNVSTMISTAVTXARQTZLABCLDX

Will LXEO reach…?

Will LXEO reach $5.00?Will LXEO reach $10.00?Will LXEO reach $20.00?

Or see the full LXEO price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare LXEO

LXEO vs ASTHLXEO vs QURELXEO vs CPHILXEO vs ACHLXEO vs AXSMLXEO vs WRBY

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.